Ischemia-modified albumin in gynecology
Künye
Kıncı MF, Kasap B, Sivaslıoğlu AA. Ischemia-modified albumin in gynecology. Biomark Med. 2021 Mar 12. doi: 10.2217/bmm-2020-0616. Epub ahead of print. PMID: 33709783.Özet
Background: Ischemia-modified albumin (IMA) is an oxidative stress marker used to assess the presence and severity of oxidative stress. This marker was first used for early diagnosis of myocardial ischemia. Materials & methods: A variety of IMA studies were carried out to show the effect of oxidative stress on gynecological disorders. Conclusion: This analysis summarizes the literature by conducting electronic research on the relationship between IMA and gynecological disorders